Elahere for Peritoneal Cancer User Reviews
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Elahere (mirvetuximab soravtansine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
"I have been on Elahere for over one year. Initially, I was receiving an infusion every three weeks, but after the sixth infusion and increasing side effects, I went to every six weeks and reduced the dosage. So far, my CA-125 is holding steady, lower than 15! I wouldn’t be able to handle the side effects if I was getting it every three weeks. I have high blood pressure, eye issues, now resolved, abdominal pain, severe constipation, managed with lots of stool softeners and laxatives, neuropathy, and fatigue. I keep wanting to stop but am afraid that it will come back if I do. Elahere is the first thing that has kept me in remission for more than three months. I am grateful."